Essex Bio-Technology (SEHK:1061) - Hisse Senedi Fiyatı, Haberler ve Analizler

1061 Stoklara Genel Bakış

1061 temel anali̇z
Kar Tanesi Skoru
Değerleme	2/6
Gelecekteki Büyüme	0/6
Geçmiş Performans	3/6
Finansal Sağlık	6/6
Temettüler	4/6

Ödüller

Fiyat-Kazanç oranı ( 5.7 x) Hong Kong piyasasının ( 9.6 x) altındadır

Kazançlar son 5 yılda yılda 0.01% oranında arttı

Risk Analizi

Kararsız temettü geçmişi

Essex Bio-Technology Limited Rakipler

Shandong Boan Biotechnology

SEHK:6955

HK$4.7b

Uni-Bio Science Group

SEHK:690

HK$376.2m

TOT BIOPHARM International

SEHK:1875

HK$1.3b

HBM Holdings

SEHK:2142

HK$857.8m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Essex Bio-Technology
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	HK$2.65
52 Haftanın En Yüksek Seviyesi	HK$3.10
52 Haftanın En Düşük Seviyesi	HK$1.96
Beta	0.16
11 Aylık Değişim	-5.36%
3 Aylık Değişim	7.29%
1 Yıllık Değişim	3.11%
33 Yıllık Değişim	-45.70%
5 Yıllık Değişim	-57.80%
Halka arzdan bu yana değişim	167.68%

Son Haberler & Güncellemeler

Essex Bio-Technology Limited (HKG:1061) Surges 29% Yet Its Low P/E Is No Reason For Excitement

Oct 09

Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's

Aug 29

Recent updates

Essex Bio-Technology Limited (HKG:1061) Surges 29% Yet Its Low P/E Is No Reason For Excitement

Oct 09

Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's

Aug 29

Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055

May 02

Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055

Mar 30

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Jun 29

Is Essex Bio-Technology (HKG:1061) A Risky Investment?

Mar 31

If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today

Mar 13

How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Feb 15

Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?

Jan 25

Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Jan 04

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Dec 13

Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters

Nov 23

Hissedar Getirileri

	1061	HK Biotechs	HK Pazar
7D	2.3%	-9.2%	-2.7%
1Y	3.1%	-18.2%	10.9%

Getiri vs. Endüstri: 1061 geçen yıl % -18.2 oranında getiri sağlayan Hong Kong Biotechs sektörünü aştı.

Getiri vs Piyasa: 1061 geçen yıl % 10.9 oranında getiri sağlayan Hong Kong Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is 1061's price volatile compared to industry and market?
1061 volatility
1061 Average Weekly Movement	5.8%
Biotechs Industry Average Movement	10.9%
Market Average Movement	9.0%
10% most volatile stocks in HK Market	19.0%
10% least volatile stocks in HK Market	4.2%

İstikrarlı Hisse Senedi Fiyatı: 1061 son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: 1061 'nin haftalık oynaklığı ( 6% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
1990	1,459	Haizhou Fang	www.essexbio.com

Bir yatırım holding şirketi olan Essex Bio-Technology Limited, Çin Halk Cumhuriyeti'nde, Hong Kong'da ve uluslararası alanda biyo-farmasötik ürünler geliştirmekte, üretmekte, dağıtmakta ve satmaktadır. Şirket, Oftalmoloji ve Cerrahi segmentleri aracılığıyla faaliyet göstermektedir. Hücresel çoğalma, farklılaşma ve göçün tedavisi için terapötik fibroblast büyüme faktörü ürünlerini araştırır ve geliştirir.

Essex Bio-Technology Limited Temel Bilgiler Özeti

Essex Bio-Technology'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
1061 temel i̇stati̇sti̇kler
Piyasa değeri	HK$1.47b
Kazançlar(TTM)	HK$262.89m
Gelir(TTM)	HK$1.62b

5.7x

F/K Oranı

0.9x

P/S Oranı

1061 aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
1061 gelir tablosu (TTM)
Gelir	HK$1.62b
Gelir Maliyeti	HK$165.38m
Brüt Kâr	HK$1.45b
Diğer Giderler	HK$1.19b
Kazançlar	HK$262.89m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	0.46
Brüt Marj	89.78%
Net Kâr Marjı	16.24%
Borç/Özkaynak Oranı	15.2%

1061 uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

4.5%

Mevcut Temettü Verimi

23%

Ödeme Oranı

1061 Stoklara Genel Bakış

Ödüller

Risk Analizi

Essex Bio-Technology Limited Rakipler

SEHK:6955

HK$4.7b

SEHK:690

HK$376.2m

SEHK:1875

HK$1.3b

SEHK:2142

HK$857.8m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Essex Bio-Technology Limited (HKG:1061) Surges 29% Yet Its Low P/E Is No Reason For Excitement

Investor sentiment improves as stock rises 19%

First half dividend increased to HK$0.06

Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's

First half 2024 earnings released: EPS: HK$0.28 (vs HK$0.30 in 1H 2023)

Essex Bio-Technology Limited to Report First Half, 2024 Results on Aug 26, 2024

Recent updates

Essex Bio-Technology Limited (HKG:1061) Surges 29% Yet Its Low P/E Is No Reason For Excitement

Investor sentiment improves as stock rises 19%

First half dividend increased to HK$0.06

Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's

First half 2024 earnings released: EPS: HK$0.28 (vs HK$0.30 in 1H 2023)

Essex Bio-Technology Limited to Report First Half, 2024 Results on Aug 26, 2024

Essex Bio-Technology Limited Declares Final Dividend for the Year Ended 31 December 2023

Upcoming dividend of HK$0.045 per share

Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement

Now 21% overvalued

Now 22% overvalued

Essex Bio-Technology Limited Proposes Final Ordinary Dividend for the Financial Year Ended 31 December 2023, Payable June 17, 2024

Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)

Essex Bio-Technology Limited, Annual General Meeting, May 28, 2024

Full year 2023 earnings: EPS misses analyst expectations

New minor risk - Financial data availability

Essex Bio-Technology Limited to Report Fiscal Year 2023 Results on Mar 18, 2024

Investor sentiment deteriorates as stock falls 16%

Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet

Upcoming dividend of HK$0.045 per share at 2.0% yield

First half 2023 earnings released: EPS: HK$0.30 (vs HK$0.24 in 1H 2022)

Essex Bio-Technology Limited to Report First Half, 2023 Results on Aug 16, 2023

Essex Bio-Technology Limited Provides Update on the Phase 1/2 Clinical Study in Relation to the Co-Development of the Licensed Product with Henlius for the Treatment of Exudative (Wet) Age-Related Macular Degeneration

Less than half of directors are independent

Essex Bio-Technology Limited Declares Final Dividend for the Year Ended 31 December 2022

Upcoming dividend of HK$0.025 per share at 1.8% yield

Now 21% undervalued after recent price drop

Essex Bio-Technology Limited Completes First Patient First Dose in the United States in an International Multi-Centre Phase 3 Clinical Study

Essex Bio-Technology Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022

Investor sentiment improved over the past week

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Price target decreased to HK$6.00

Less than half of directors are independent

Consensus revenue estimates fall by 18%

Upcoming dividend of HK$0.04 per share

Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04

First half 2022 earnings released: EPS: HK$0.24 (vs HK$0.28 in 1H 2021)

Essex Bio-Technology Limited Declares Interim Dividend for the Six Months Ended 30 June 2022, Payable on September 21, 2022

Essex Bio-Technology Limited Provides Earnings Guidance for the Six Months Ended June 30, 2022

Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?

Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055

Essex Bio-Technology Limited Approves Final Dividend for the Year Ended December 31, 2021

Price target increased to HK$7.00

Less than half of directors are independent

Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055

Investor sentiment deteriorated over the past week

Upcoming dividend of HK$0.04 per share

First half 2021 earnings released: EPS HK$0.28 (vs HK$0.085 in 1H 2020)

Investor sentiment improved over the past week

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Essex Bio-Technology Limited Approves Final Dividend for the Year Ended December 31, 2021 at the Annual General Meeting held on May 12, 2021

Upcoming dividend of HK$0.05 per share

Is Essex Bio-Technology (HKG:1061) A Risky Investment?

Essex Bio-Technology Limited Announces Dividend for the Year Ended December 31, 2020, Payable on 1 June 2021

If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today

Essex Bio-Technology Limited, Annual General Meeting, May 12, 2021

Full year 2020 earnings released: EPS HK$0.38 (vs HK$0.52 in FY 2019)